End-of-day quote
Taiwan S.E.
06:00:00 2024-05-02 pm EDT
|
5-day change
|
1st Jan Change
|
149
TWD
|
-1.65%
|
|
-1.65%
|
+50.05%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
9,306
|
8,792
|
15,818
|
6,677
|
10,200
|
15,305
|
Enterprise Value (EV)
1 |
9,306
|
8,792
|
15,818
|
6,677
|
10,200
|
15,305
|
P/E ratio
|
-
|
-
|
-
|
-
|
-
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.05
x
|
2.05
x
|
3.5
x
|
1.72
x
|
2.39
x
|
3.18
x
|
EV / Revenue
|
2.05
x
|
2.05
x
|
3.5
x
|
1.72
x
|
2.39
x
|
3.18
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
40.6
x
|
13.3
x
|
20.1
x
|
20.7
x
|
FCF Yield
|
-
|
-
|
2.46%
|
7.54%
|
4.98%
|
4.82%
|
Price to Book
|
-
|
-
|
-
|
2.26
x
|
3.25
x
|
-
|
Nbr of stocks (in thousands)
|
102,716
|
102,716
|
102,716
|
102,716
|
102,716
|
102,716
|
Reference price
2 |
90.60
|
85.60
|
154.0
|
65.00
|
99.30
|
149.0
|
Announcement Date
|
2/25/20
|
2/24/21
|
2/23/22
|
2/22/23
|
3/1/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
4,531
|
4,296
|
4,513
|
3,889
|
4,264
|
4,807
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
752.4
|
733.4
|
767.6
|
438
|
610.8
|
826
|
Operating Margin
|
16.61%
|
17.07%
|
17.01%
|
11.26%
|
14.32%
|
17.18%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
389.3
|
503.4
|
507.7
|
738
|
FCF margin
|
-
|
-
|
8.62%
|
12.94%
|
11.91%
|
15.35%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/25/20
|
2/24/21
|
2/23/22
|
2/22/23
|
3/1/24
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2023 Q2
|
2023 Q4
|
---|
Net sales
1 |
1,180
|
1,168
|
-
|
1,048
|
727.6
|
1,130
|
997.6
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
211.2
|
187.5
|
-
|
150.5
|
16.7
|
171.6
|
137.4
|
Operating Margin
|
17.9%
|
16.05%
|
-
|
14.36%
|
2.3%
|
15.18%
|
13.78%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
163.4
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
1.580
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/3/21
|
2/23/22
|
5/5/22
|
8/3/22
|
11/9/22
|
8/10/23
|
3/1/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
389
|
503
|
508
|
738
|
ROE (net income / shareholders' equity)
|
-
|
-
|
22.8%
|
14.2%
|
17.2%
|
23.7%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
15.1%
|
9.31%
|
11.4%
|
13.5%
|
Assets
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
28.70
|
30.50
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
248
|
-
|
398
|
229
|
218
|
250
|
Capex / Sales
|
5.47%
|
-
|
8.81%
|
5.89%
|
5.1%
|
5.2%
|
Announcement Date
|
2/25/20
|
2/24/21
|
2/23/22
|
2/22/23
|
3/1/24
|
-
|
Average target price
140
TWD Spread / Average Target -6.04% Consensus |
1st Jan change
|
Capi.
|
---|
| +50.05% | 474M | | +14.70% | 65.04B | | -1.61% | 47.76B | | +14.58% | 40.72B | | +20.84% | 26.88B | | +1.16% | 17.53B | | -21.87% | 16.03B | | +1.11% | 15.17B | | -11.34% | 15.06B | | -20.82% | 13.62B |
Other Specialty Chemicals
|